Merck Advances Cell Analysis with New Benchtop Flow Cytometer with Camera Detection
DARMSTADT, GERMANY |
Merck, a leading science and technology company, today launched its new CellStream™ benchtop flow cytometry system, a compact, customizable flow cytometer that uses a camera for detection. Its unique optics system and design provide researchers with unparalleled sensitivity and flexibility when analyzing cells and submicron particles. “Researchers increasingly require more power and agility in their labs and research capabilities,” said Jean-Charles Wirth, head of the Applied Solutions business unit, Life Science, at Merck. “Merck’s new CellStream™ flow cytometry system expands the limits of sensitivity, allowing scientists to tailor their instrument to their needs in immunology, cancer research and many other areas.” The CellStream™ system’s Amnis® time-delay integration and camera technology rapidly captures low-resolution cell images and converts them to high-throughput intensity data with enhanced fluorescence sensitivity. The new system can be used in a wide variety of research areas, including exosome research, where it can identify small populations unable to be seen on other cytometers. Merck developed this new technology with the same patent-protected optics system as its Amnis® flow cytometers, which are used in academic, biotech and pharmaceutical cell analysis and research applications. The CellStream™ flow cytometry system offers multiple innovative features, including:
The new CellStream™ system expands Merck’s portfolio of innovative flow cytometry platforms. |